Customers for Life?
Motley Fool Money
Challenges in Sleep Apnea Drug Adoption
This chapter delves into the early developments of a new drug for sleep apnea, focusing on the hurdles it faces for insurance coverage and the high costs compared to existing treatments. It also addresses patient reluctance to switch from traditional therapies, the emotional ties to existing devices, and the need for more data to support the drug's wider acceptance.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
